Jane Street Group, LLC Anixa Biosciences Inc Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.08 - $5.02 $241,906 - $394,275	78,541 Added 181.04%	121,924 $380,000
Q4 2023 Feb 14, 2024	BUY	$2.85 - $4.19 $123,641 - $181,774	43,383 New	43,383 $168,000
Q1 2023 May 15, 2023	BUY	$3.86 - $5.0 $238,586 - $309,050	61,810 New	61,810 $265,000
Q2 2021 Aug 16, 2021	SELL	$3.46 - $4.92 $90,281 - $128,377	-26,093 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$3.27 - $7.14 $85,324 - $186,304	26,093 New	26,093 $122,000
Q4 2020 Feb 17, 2021	SELL	$1.94 - $3.19 $35,880 - $58,999	-18,495 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$1.79 - $3.3 $33,106 - $61,033	18,495 New	18,495 $45,000

5.53M

21K

6.7K

Ticker ANIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,661,700
Market Cap $86.5M
Description
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.